Tohoku Medical and Pharmaceutical University · Unclassified

Research keywordsCYP11B2とKCNJ5変異を標的とした原発性アルドステロン症の新規創薬・CYP11B2とKCNJ5変異体を標的とした原発性アルドステロン症の新規創薬・CYP11B2とKCNJ5変異体を標的とした原発性アルドステロン症の新規治療薬の開発

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells.
• The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery.
• TET3-OGT interaction increases the stability and the presence of OGT in chromatin.
• Primary aldosteronism and obstructive sleep apnea: the strong ties between them.

• Official profile